← Back to deals

Modern at-home allergy immunotherapy that replaces years of in-office shots

acquireOnline / Digital

Asking Price

$2,899,611

Revenue

$2,200,000

Cash Flow

$126,400

UNKNOWN

Multiple

22.94x

Details

Location: Inc., CA

URL: View listing

First seen: 9/9/2026

Last seen: 9/9/2026

This is a national telehealth platform focused on physician-guided, at-home allergy immunotherapy via a subscription model, helping patients access long-term, disease-modifying treatment without frequent in-office visits, while operating a fully compliant infrastructure licensed across all 50 states with integrated clinical, pharmacy, and technology workflows that support durable recurring revenue through multi-year treatment durations, strong retention, and efficient customer acquisition, al...

Score Breakdown

No scores computed yet.